{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T15:29:56Z","timestamp":1794324596915,"version":"4.9.0"},"reference-count":134,"publisher":"ScopeMed","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.matersociomed.org\/\/?sec=licenseinfo"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.5455\/msm.2019.31.146-149","type":"journal-article","created":{"date-parts":[[2019,6,25]],"date-time":"2019-06-25T18:45:34Z","timestamp":1561488334000},"source":"Crossref","is-referenced-by-count":5,"title":["Talking Genes in Breast and Pancreatic Malignancies"],"prefix":"10.5455","member":"3407","reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA: a cancer","DOI":"10.3322\/caac.21442"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"journal for clinicians. 2018; 68(1): 7-30.","DOI":"10.3322\/caac.21442"},{"key":"ref3","unstructured":"2. Raimondi S, Maisonneuve P, Lowenfels AB. Epidemiology of pan -"},{"key":"ref4","unstructured":"creatic cancer: an overview. Nature reviews Gastroenterology &"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"hepatology. 2009; 6(12): 699-708.","DOI":"10.1038\/nrgastro.2009.177"},{"key":"ref6","unstructured":"3. Klein AP. Genetic susceptibility to pancreatic cancer. Molecular"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"carcinogenesis. 2012; 51(1): 14-24.","DOI":"10.1002\/mc.20855"},{"key":"ref8","unstructured":"4. Klein AP, Brune KA, Petersen GM, Goggins M, Tersmette AC, Of -"},{"key":"ref9","unstructured":"ferhaus GJ, et al. Prospective risk of pancreatic cancer in familial"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"pancreatic cancer kindreds. Cancer research. 2004; 64(7): 2634-2638.","DOI":"10.1158\/0008-5472.CAN-03-3823"},{"key":"ref11","unstructured":"5. Mocci E, Milne RL, Mendez-Villamil EY, Hopper JL, John EM, Andru -"},{"key":"ref12","unstructured":"lis IL, et al. Risk of pancreatic cancer in breast cancer families from"},{"key":"ref13","unstructured":"the breast cancer family registry. Cancer epidemiology, biomarkers"},{"key":"ref14","unstructured":"& prevention: a publication of the American Association for Cancer"},{"key":"ref15","unstructured":"Research, cosponsored by the American Society of Preventive Oncol -"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"ogy. 2013; 22(5): 803-811.","DOI":"10.1016\/j.seizure.2013.07.003"},{"key":"ref17","unstructured":"6. Jones S, Hruban RH, Kamiyama M, Borges M, Zhang X, Parsons DW,"},{"key":"ref18","unstructured":"et al. Exomic Sequencing Identifies PALB2 as a Pancreatic Cancer"},{"key":"ref19","unstructured":"Susceptibility Gene. Science. 2009; 324(5924): 217."},{"key":"ref20","unstructured":"7. Lubezky N, Ben-Haim M, Lahat G, Marmor S, Solar I, Brazowski E,"},{"key":"ref21","unstructured":"et al. Intraductal papillary mucinous neoplasm of the pancreas: As -"},{"key":"ref22","unstructured":"sociated cancers, family history, genetic predisposition? Surgery."},{"key":"ref23","unstructured":"2012; 151(1): 70-75."},{"key":"ref24","unstructured":"8. Lucas AL, Shakya R, Lipsyc MD, Mitchel EB, Kumar S, Hwang C, et"},{"key":"ref25","unstructured":"al. High Prevalence of BRCA1 and BRCA2 Germline Mutations with"},{"key":"ref26","unstructured":"Loss of Heterozygosity in a Series of Resected Pancreatic Adenocar -"},{"key":"ref27","unstructured":"cinoma and Other Neoplastic Lesions. Clinical cancer research: an"},{"key":"ref28","unstructured":"official journal of the American Association for Cancer Research."},{"key":"ref29","unstructured":"2013; 19(13): 3396-3403."},{"key":"ref30","unstructured":"9. Riall TS, Stager VM, Nealon WH, Townsend CM, Kuo Y-f, Goodwin"},{"key":"ref31","unstructured":"JS, et al. Incidence of Additional Primary Cancers in Patients with"},{"key":"ref32","unstructured":"Invasive Intraductal Papillary Mucinous Neoplasms and Sporadic"},{"key":"ref33","unstructured":"Pancreatic Adenocarcinomas. Journal of the American College of"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Surgeons. 2007; 204(5): 803-813.","DOI":"10.1016\/j.jamcollsurg.2007.01.015"},{"key":"ref35","unstructured":"10. Thull DL, Vogel VG. Recognition and management of hereditary"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"breast cancer syndromes. The oncologist. 2004; 9(1): 13-24.","DOI":"10.1634\/theoncologist.9-1-13"},{"key":"ref37","unstructured":"11. Goggins M, Schutte M, Lu J, Moskaluk CA, Weinstein CL, Petersen"},{"key":"ref38","unstructured":"GM, et al. Germline BRCA2 gene mutations in patients with appar -"},{"key":"ref39","unstructured":"ently sporadic pancreatic carcinomas. Cancer research. 1996; 56(23):"},{"key":"ref40","unstructured":"12. Phelan CM, Lancaster JM, Tonin P, Gumbs C, Cochran C, Carter R,"},{"key":"ref41","unstructured":"et al. Mutation analysis of the BRCA2 gene in 49 site-specific breast"},{"key":"ref42","doi-asserted-by":"crossref","unstructured":"cancer families. Nat Genet. 1996; 13(1): 120-122.","DOI":"10.1038\/ng0596-120"},{"key":"ref43","unstructured":"13. The Breast Cancer Linkage C. Cancer Risks in BRCA2 Mutation Car -"},{"key":"ref44","doi-asserted-by":"crossref","unstructured":"riers. JNCI: Journal of the National Cancer Institute. 1999; 91(15):","DOI":"10.1093\/jnci\/91.1.15"},{"key":"ref45","unstructured":"14. Couch FJ, Johnson MR, Rabe KG, Brune K, de Andrade M, Goggins"},{"key":"ref46","unstructured":"M, et al. The prevalence of BRCA2 mutations in familial pancreatic"},{"key":"ref47","unstructured":"cancer. Cancer epidemiology, biomarkers & prevention: a publication"},{"key":"ref48","unstructured":"of the American Association for Cancer Research, cosponsored by the"},{"key":"ref49","unstructured":"American Society of Preventive Oncology. 2007; 16(2): 342-346."},{"key":"ref50","unstructured":"15. Lal G, Liu G, Schmocker B, Kaurah P, Ozcelik H, Narod SA, et al. In -"},{"key":"ref51","unstructured":"herited predisposition to pancreatic adenocarcinoma: role of family"},{"key":"ref52","unstructured":"history and germ-line p16, BRCA1, and BRCA2 mutations. Cancer"},{"key":"ref53","doi-asserted-by":"crossref","unstructured":"research. 2000; 60(2): 409-416.","DOI":"10.1007\/s11912-000-0060-6"},{"key":"ref54","unstructured":"16. Murphy KM, Brune KA, Griffin C, Sollenberger JE, Petersen GM,"},{"key":"ref55","unstructured":"Bansal R, et al. Evaluation of candidate genes MAP2K4, MADH4,"},{"key":"ref56","unstructured":"ACVR1B, and BRCA2 in familial pancreatic cancer: deleterious"},{"key":"ref57","unstructured":"BRCA2 mutations in 17%. Cancer research. 2002; 62(13): 3789-3793."},{"key":"ref58","unstructured":"17. Hahn SA, Greenhalf B, Ellis I, Sina-Frey M, Rieder H, Korte B, et al."},{"key":"ref59","unstructured":"BRCA2 germline mutations in familial pancreatic carcinoma. Journal"},{"key":"ref60","unstructured":"of the National Cancer Institute. 2003; 95(3): 214-221."},{"key":"ref61","unstructured":"18. Goggins M, Hruban RH, Kern SE. BRCA2 is inactivated late in the"},{"key":"ref62","unstructured":"development of pancreatic intraepithelial neoplasia: evidence and"},{"key":"ref63","doi-asserted-by":"crossref","unstructured":"implications. Am J Pathol. 2000; 156(5): 1767-1771.","DOI":"10.1016\/S0002-9440(10)65047-X"},{"key":"ref64","unstructured":"19. Ozcelik H, Schmocker B, Di Nicola N, Shi XH, Langer B, Moore M, et al. Germline BRCA2 6174delT mutations in Ashkenazi Jewish pan -"},{"key":"ref65","doi-asserted-by":"crossref","unstructured":"creatic cancer patients. Nat Genet. 1997; 16(1): 17-18.","DOI":"10.1038\/ng0597-17"},{"key":"ref66","unstructured":"20. Ferrone CR, Levine DA, Tang LH, Allen PJ, Jarnagin W, Brennan MF,"},{"key":"ref67","unstructured":"et al. BRCA germline mutations in Jewish patients with pancreatic"},{"key":"ref68","unstructured":"adenocarcinoma. Journal of clinical oncology: official journal of the"},{"key":"ref69","doi-asserted-by":"crossref","unstructured":"American Society of Clinical Oncology. 2009; 27(3): 433-438.","DOI":"10.1200\/JCO.2008.18.5546"},{"key":"ref70","unstructured":"21. Holter S, Borgida A, Dodd A, Grant R, Semotiuk K, Hedley D, et al."},{"key":"ref71","unstructured":"Germline BRCA Mutations in a Large Clinic-Based Cohort of Patients"},{"key":"ref72","unstructured":"With Pancreatic Adenocarcinoma. Journal of clinical oncology: of -"},{"key":"ref73","unstructured":"ficial journal of the American Society of Clinical Oncology. 2015;"},{"key":"ref74","unstructured":"33(28): 3124-3129."},{"key":"ref75","unstructured":"22. Thompson D, Easton DF. Cancer Incidence in BRCA1 mutation carri -"},{"key":"ref76","doi-asserted-by":"crossref","unstructured":"ers. Journal of the National Cancer Institute. 2002; 94(18): 1358-1365.","DOI":"10.1093\/jnci\/94.18.1358"},{"key":"ref77","unstructured":"23. Brose MS, Rebbeck TR, Calzone KA, Stopfer JE, Nathanson KL, Weber"},{"key":"ref78","unstructured":"BL. Cancer risk estimates for BRCA1 mutation carriers identified in"},{"key":"ref79","unstructured":"a risk evaluation program. Journal of the National Cancer Institute."},{"key":"ref80","unstructured":"2002; 94(18): 1365-1372."},{"key":"ref81","unstructured":"24. Axilbund JE, Argani P, Kamiyama M, Palmisano E, Raben M, Borges"},{"key":"ref82","unstructured":"M, et al. Absence of germline BRCA1 mutations in familial pancreatic"},{"key":"ref83","doi-asserted-by":"crossref","unstructured":"cancer patients. Cancer biology & therapy. 2009; 8(2): 131-135.","DOI":"10.4161\/cbt.8.2.7136"},{"key":"ref84","unstructured":"25. Tischkowitz M, Sabbaghian N, Ray AM, Lange EM, Foulkes WD,"},{"key":"ref85","unstructured":"Cooney KA. Analysis of the gene coding for the BRCA2-interacting"},{"key":"ref86","doi-asserted-by":"crossref","unstructured":"protein PALB2 in hereditary prostate cancer. The Prostate. 2008;","DOI":"10.1038\/pcan.2008.1"},{"key":"ref87","unstructured":"68(6): 675-678."},{"key":"ref88","unstructured":"26. Slater EP, Langer P, Niemczyk E, Strauch K, Butler J, Habbe N, et al."},{"key":"ref89","unstructured":"PALB2 mutations in European familial pancreatic cancer families."},{"key":"ref90","doi-asserted-by":"crossref","unstructured":"Clinical genetics. 2010; 78(5): 490-494.","DOI":"10.1111\/j.1399-0004.2010.01425.x"},{"key":"ref91","unstructured":"27. Jones S, Hruban RH, Kamiyama M, Borges M, Zhang X, Parsons DW,"},{"key":"ref92","unstructured":"et al. Exomic sequencing identifies PALB2 as a pancreatic cancer"},{"key":"ref93","unstructured":"susceptibility gene. Science. 2009; 324(5924): 217."},{"key":"ref94","unstructured":"28. Conlon KC. Intraductal papillary mucinous tumors of the pancreas."},{"key":"ref95","unstructured":"Journal of clinical oncology: official journal of the American Society"},{"key":"ref96","doi-asserted-by":"crossref","unstructured":"of Clinical Oncology. 2005; 23(20): 4518-4523.","DOI":"10.1200\/JCO.2005.22.517"},{"key":"ref97","unstructured":"29. Pedrazzoli S, Sperti C, Pasquali C, Bissoli S, Chierichetti F. Com -"},{"key":"ref98","unstructured":"parison of International Consensus Guidelines versus 18-FDG PET in"},{"key":"ref99","unstructured":"detecting malignancy of intraductal papillary mucinous neoplasms"},{"key":"ref100","doi-asserted-by":"crossref","unstructured":"of the pancreas. Ann Surg. 2011; 254(6): 971-976.","DOI":"10.1097\/SLA.0b013e3182383137"},{"key":"ref101","unstructured":"30. Baumgaertner I, Corcos O, Couvelard A, Sauvanet A, Rebours V, Vul -"},{"key":"ref102","unstructured":"lierme MP, et al. Prevalence of extrapancreatic cancers in patients"},{"key":"ref103","unstructured":"with histologically proven intraductal papillary mucinous neoplasms"},{"key":"ref104","unstructured":"of the pancreas: a case-control study. Am J Gastroenterol. 2008;"},{"key":"ref105","unstructured":"103(11): 2878-2882."},{"key":"ref106","unstructured":"31. Reid-Lombardo KM, Mathis KL, Wood CM, Harmsen WS, Sarr MG."},{"key":"ref107","unstructured":"Frequency of extrapancreatic neoplasms in intraductal papillary"},{"key":"ref108","unstructured":"mucinous neoplasm of the pancreas: implications for management."},{"key":"ref109","doi-asserted-by":"crossref","unstructured":"Ann Surg. 2010; 251(1) :64-69.","DOI":"10.1016\/j.desal.2009.09.142"},{"key":"ref110","unstructured":"32. Marchegiani G, Malleo G, D\u2019Haese JG, Wenzel P, Keskin M, Pugliese L,"},{"key":"ref111","unstructured":"et al. Association between pancreatic intraductal papillary mucinous"},{"key":"ref112","unstructured":"neoplasms and extrapancreatic malignancies. Clinical gastroenter -"},{"key":"ref113","unstructured":"ology and hepatology : the official clinical practice journal of the"},{"key":"ref114","unstructured":"American Gastroenterological Association. 2015; 13(6): 1162-1169."},{"key":"ref115","unstructured":"33. Verna EC, Hwang C, Stevens PD, Rotterdam H, Stavropoulos SN,"},{"key":"ref116","unstructured":"Sy CD, et al. Pancreatic cancer screening in a prospective cohort of"},{"key":"ref117","unstructured":"high-risk patients: a comprehensive strategy of imaging and genetics."},{"key":"ref118","unstructured":"Clinical cancer research: an official journal of the American Associa -"},{"key":"ref119","doi-asserted-by":"crossref","unstructured":"tion for Cancer Research. 2010; 16(20): 5028-5037.","DOI":"10.1158\/1078-0432.CCR-09-3209"},{"key":"ref120","unstructured":"34. Canto MI, Harinck F, Hruban RH, Offerhaus GJ, Poley JW, Kamel I,"},{"key":"ref121","unstructured":"et al. International Cancer of the Pancreas Screening (CAPS) Con -"},{"key":"ref122","unstructured":"sortium summit on the management of patients with increased risk"},{"key":"ref123","doi-asserted-by":"crossref","unstructured":"for familial pancreatic cancer. Gut. 2013; 62(3): 339-347.","DOI":"10.1136\/gutjnl-2012-303108"},{"key":"ref124","unstructured":"35. Brand RE, Lerch MM, Rubinstein WS, Neoptolemos JP, Whitcomb"},{"key":"ref125","unstructured":"DC, Hruban RH, et al. Advances in counselling and surveillance of"},{"key":"ref126","doi-asserted-by":"crossref","unstructured":"patients at risk for pancreatic cancer. Gut. 2007; 56(10): 1460-1469.","DOI":"10.1136\/gut.2006.108456"},{"key":"ref127","unstructured":"36. Lucas AL, Frado LE, Hwang C, Kumar S, Khanna LG, Levinson EJ, et al."},{"key":"ref128","unstructured":"BRCA1 and BRCA2 germline mutations are frequently demonstrated"},{"key":"ref129","unstructured":"in both high-risk pancreatic cancer screening and pancreatic cancer"},{"key":"ref130","doi-asserted-by":"crossref","unstructured":"cohorts. Cancer. 2014; 120(13): 1960-1967.","DOI":"10.1002\/cncr.28662"},{"key":"ref131","unstructured":"37. Pugliese L, Keskin M, Maisonneuve P, D\u2019Haese JG, Marchegiani G,"},{"key":"ref132","unstructured":"Wenzel P, et al. Increased incidence of extrapancreatic neoplasms in"},{"key":"ref133","unstructured":"patients with IPMN: Fact or fiction? Pancreatology: official journal"},{"key":"ref134","unstructured":"of the International Association of Pancreatology (IAP). 2015; 15(3):"}],"container-title":["Materia Socio Medica"],"original-title":[],"link":[{"URL":"https:\/\/ejmanager.com\/mnstemps\/16\/16-1561181494.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T18:07:37Z","timestamp":1791482857000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ejmanager.com\/mnstemps\/16\/16-1561181494.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":134,"URL":"https:\/\/doi.org\/10.5455\/msm.2019.31.146-149","relation":{},"ISSN":["1512-7680"],"issn-type":[{"value":"1512-7680","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]}}}